IL-7-regulated homeostatic maintenance of recent thymic emigrants in association with caspase-mediated cell proliferation and apoptotic cell death

Journal of Immunology

Volumn 170, Issue 9, 2003, Pages 4524-4531

  O'Neill, Rose M ^a   Hassan, Jaythoon ^a   Reen, Denis J ^a,b  

^a OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^b Dublin Molecular Medicine Centre   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 3 INHIBITOR; CASPASE 8; CASPASE INHIBITOR; FAS ANTIGEN; INTERLEUKIN 7;

APOPTOSIS; ARTICLE; CELL CULTURE; CULTURE MEDIUM; ENZYME ACTIVATION; HOMEOSTASIS; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MOLECULAR MECHANICS; MOLECULAR RECOGNITION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; T LYMPHOCYTE; THYMOCYTE; UPREGULATION;

EID: 0037408324     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.9.4524     Document Type: Article

References (46)

1. Takahashi, N., K. Imanishi, H. Nishida, and T. Uchiyama. 1995. Evidence for immunologic immaturity of cord blood T cells: cord blood T cells are susceptible to tolerance induction to in vitro stimulation with a superantigen. J. Immunol. 155:5213.
2. McDouall, R. M., A. J. Suitters, H. Smith, M. H. Yacoub, and M. L. Rose. 1994. Increased cyclosporine sensitivity of T cells from cord blood compared with those from the adult. Clin. Exp. Immunol. 95:519.
3. Kavelaars, A., J. Zijlstra, J. M. Bakker, E. P. Van Rees, G. H. Visser, B. J. Zegers, and C. J. Heijnen. 1995. Increased dexamethasone sensitivity of neonatal leukocytes: different mechanisms of glucocorticoid inhibition of T cell proliferation in adult and neonatal cells. Eur. J. Immunol. 25:1346.
4. Adkins, B. 1999. T-cell function in newborn mice and humans. Immunol. Today 20:330.
5. Chalmers, I. M., G. Janossy, M. Contreras, and C. Navarrete. 1998. Intracellular cytokine profile of cord and adult blood lymphocytes. Blood 92:11.
6. Hassan, J., and D. J. Reen. 2001. Human recent thymic emigrants: identification, expansion, and survival characteristics. J. Immunol. 167:1970.
7. Wilson, C. B., and D. B. Lewis. 1990. Basis and implications of selectively diminished cytokine production in neonatal susceptibility to infection. Rev. Infect. Dis. 12(Suppl. 4):S410.
8. Berzins, S. P., R. L. Boyd, and J. F. Miller. 1998. The role of the thymus and recent thymic migrants in the maintenance of the adult peripheral lymphocyte pool. J. Exp. Med. 187:1839.
9. + T cells. Proc. Natl. Acad. Sci. USA 98:9277.
10. + T cells enables preservation of a naive repertoire. J. Immunol. 161:5909.
11. Hofmeister, R., A. R. Khalad, N. Benbernou, E. Rajnavolgyi, K. Muegge, and S. K. Duram. 1999. Interleukin-7: physiological roles and mechanisms of action. Cytokine Growth Factor Rev. 10:41.
12. + T cells. Eur. J. Immunol. 28: 3057.
13. Akashi, K., M. Kondo, U. von Freeden-Jeffry, R. Murray, and I. L. Weissman. 1997. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 89:1033.
14. -/- mice. Cell 89:1011.
15. Miossec, C., V. Dutilleul, F. Fassy, and A. Diu-Hercend. 1997. Evidence for CPP32 activation in the absence of apoptosis during T lymphocyte stimulation. J. Biol. Chem. 272:13459.
16. Wilhelm, S., H. Wagner, and G. Hacker. 1998. Activation of caspase-3-like enzymes in non-apoptotic T cells. Eur. J. Immunol. 28:891.
17. Alam, A., L. Y. Cohen, S. Aouad, and R. P. Sekaly. 1999. Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J. Exp. Med. 190:1879.
18. Kennedy, N. J., T. Kataoka, J. Tschopp, and R. C. Budd. 1999. Caspase activation is required for T cell proliferation. J. Exp. Med. 190:1891.
19. Newton, K., and A. Strasser. 1998. The Bcl-2 family and cell death regulation. Curr. Opin. Genet. Dev. 8:68.
20. O'Reilly, L. A., D. C. Huang, and A. Strasser. 1996. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J. 15:6979.
21. Zermati, Y., C. Garrido, S. Amsellem, S. Fishelson, D. Bouscary, F. Valensi, B. Varet, E. Solary, and O. Hermine. 2001. Caspase activation is required for terminal erythroid differentiation. J. Exp. Med. 193:247.
22. Mukerjee, N., K. M. McGinnis, M. E. Gnegy, and K. K. Wang, 2001. Caspase-mediated calcineurin activation contributes to IL-2 release during T cell activation. Biochim. Biophys. Acta 285:1192.
23. Kohler, C., S. Orrenius, and B. Zhivotovsky. 2002. Evaluation of caspase activity in apoptotic cells. J. Immunol. Methods 265:97.
24. Aggarwal, S., S. Gollapudi, L. Yel, A. S. Gupta, and S. Gupta. 2000. TNF-α-induced apoptosis in neonatal lymphocytes: TNFRp55 expression and down-stream pathways of apoptosis. Genes Immun. 1:271.
25. Aggarwal, S., A. Gupta, S. Nagata, and S. Gupta. 1997. Programmed cell death (apoptosis) in cord blood lymphocytes. J. Clin. Immunol. 17:63.
26. Aggarwal, S., S. Gollapudi, and S. Gupta. 1999. Increased TNF-α-induced apoptosis in lymphocytes from aged humans: changes in TNF-α receptor expression and activation of caspases. J. Immunol. 162:2154.
27. Namen, A. E., S. Lupton, and K. Hjerrild. 1988. Stimulation of B cell progenitors by cloned murine interleukin-7. Nature 333:571.
28. Peschon, J. J., P. J. Morrissey, K. H. Grabstein, F. J. Ramsdell. E. Maraskovsky, B. C. Gliniak, L. S. Park, S. F. Ziegler, D. E. Williams, C. B. Ware, et al. 1994. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180:1955.
29. Vella, A., T. K. Teague, J. Ihle, J. Kappler, and P. Marrack. 1997. Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4. J. Exp. Med. 186:325.
30. Buckley, A. F., C. T. Kuo, and J. M. Leiden. 2001. Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc-dependent pathway. Nat. Immun. 2:698.
31. Schober, S. L., C. T. Kuo, K. S. Schluns, L. Lefrancois, J. M. Leiden, and S. C. Jameson. 1999. Expression of the transcription factor lung Kruppel-like factor is regulated by cytokines and correlates with survival of memory T cells in vitro and in vivo. J. Immunol. 163:3662.
32. Smyth, M. J., Y. Norihisa, J. R. Gerard, H. A. Young, and J. R. Ortaldo. 1991. IL-7 regulation of cytotoxic lymphocytes: pore-forming protein gene expression, interferon-γ production, and cytotoxicity of human peripheral blood lymphocyte subsets. Cell. Immunol. 138:390.
33. Morrissey, P. J., R. G. Goodwin, R. P. Nordan, D. Anderson, K. H. Grabstein, D. Cosman, J. Sims, S. Lupton, B. Acres, and S. G. Reed. 1989. Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells. J. Exp. Med. 169:707.
34. Fry, T. J., and C. L. Mackall. 2001. Interleukin-7: master regulator of peripheral T-cell homeostasis? Trends Immunol. 22:564.
35. Eamshaw, W. C., L. M. Martins, and S. H. Kaufmann. 1999. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 68:383.
36. Zhang, J., D. Cado, A. Chen, N. H. Kabra, and A. Winoto. 1998. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort 1. Nature 392:296.
37. Chun, H. J., L. Zheng, M. Ahmad, J. Wang, C. K. Speirs, R. M. Siegel, J. K. Dale, J. Puck, J. Davis, C. G. Hall, et al. 2002. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 419:395.
38. Walsh, C. M., B. G. Wen, A. M. Chinnaiyan, K. O'Rourke, V. M. Dixit, and S. M. Hedrick. 1998. A role for FADD in T cell activation and development. Immunity 8:439.
39. Tschopp, J., M. Irmler, and M. Thome. 1998. Inhibition offas death signals by FLIPs. Curr. Opin. Immunol. 10:552.
40. Kataoka, T., R. C. Budd, N. Holler, M. Thome, F. Martinon, M. Irmler, K. Burns, M. Hahne, N. Kennedy, M. Kovacsovics, and J. Tschopp. 2000. The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways. Curr. Biol. 10:640.
41. Algeciras-Schimnich, A., T. S. Griffith, D. H. Lynch, and C. V. Paya. 1999. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis. J. Immunol. 162:5205.
42. Moulian, N., J. Bidault, C. Planche, and S. Berrih-Aknin. 1998. Two signaling pathways can increase fas expression in human thymocytes. Blood 92:1297.
43. Siegel, R. M., F. K. Chan, H. J. Chun, and M. J. Lenardo. 2000. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat. Immun. 1:469.
44. Kataoka, T., M. Ito, R. C. Budd, J. Tschopp, and K. Nagai. 2002. Expression level of c-FLIP versus Fas determines susceptibility to Fas ligand-induced cell death in murine thymoma EL-4 cells. Exp. Cell Res. 273:256.
45. Lu, L., and A. W. Thomson. 2002. Manipulation of dendritic cells for tolerance induction in transplantation and autoimmune disease. Transplantation 73:S19.
46. Ge, X., Y. M. Fu, Y. Q. Li, and G. G. Meadows. 2002. Activation of caspases and cleavage of Bid are required for tyrosine and phenylalanine deficiency-induced apoptosis of human A375 melanoma cells. Arch. Biochem. Biophys. 403:50.